Src leads to a novel mechanism of resistance to PI3K inhibitors through regulation of PI3K/p85 activation

被引：0
|
作者：
Kim, Gui Chul
Nam, Hae Yun
Lee, Hyang Ju
Kim, Min Kyung
Lee, Geun Hee
Han, Myung Woul
Kim, Seong Who
Kim, Sang Yoon
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
144
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The regulatory subunits of PI3K, p85α and p85β, differentially affect BRD7-mediated regulation of insulin signaling
    Lee, Junsik M.
    Liu, Renyan
    Park, Sang Won
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2021, 13 (12) : 889 - 901
  • [32] Pathogenic Role of PI3K P85α Subunit in a Murine Colitis Model Through the Regulation of Intestinal Macrophage Functions
    Hamada, Takayuki
    Hayashi, Shusaku
    Kadowaki, Makoto
    GASTROENTEROLOGY, 2014, 146 (05) : S646 - S646
  • [33] Dual loss of PI3Kα and PI3Kγ signaling leads to an age-dependent cardiomyopathy
    Zhabyeyev, Pavel
    McLean, Brent
    Patel, Vaibhav B.
    Wang, Wang
    Ramprasath, Tharmarajan
    Oudit, Gavin Y.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 77 : 155 - 159
  • [34] Autophagy: A potentially druggable resistance mechanism to PI3K/mTOR inhibitors
    Amaravadi, Ravi
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [35] Essential role of PI3Kδ and PI3Kγ in thymocyte survival
    Swat, W
    Montgrain, V
    Doggett, TA
    Douangpanya, J
    Puri, K
    Vermi, W
    Diacovo, TG
    BLOOD, 2006, 107 (06) : 2415 - 2422
  • [36] The essential role of PI3Kδ and PI3Kγ in thymocyte survival
    Diacovo, Thomas
    Montgrain, Vivianne
    Doggett, Teresa
    Douangpanya, Jason
    Puri, Kamal
    Vermi, William
    Swat, Wojciech
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S313 - S313
  • [37] PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases
    Cushing, Timothy D.
    Metz, Daniela P.
    Whittington, Douglas A.
    McGee, Lawrence R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8559 - 8581
  • [38] The essential of PI3Kγ and PI3Kδ in thymocyte survival.
    Diacovo, TG
    Vermi, W
    Montgrain, V
    Douangpanya, J
    Doggett, T
    Puri, K
    Swat, W
    BLOOD, 2005, 106 (11) : 63B - 63B
  • [39] Adaptive and acquired mechanisms of resistance to PI3K inhibitors
    Chandarlapaty, Sarat
    Scaltriti, Maurizio
    Will, Marie
    Li, Zhiqiang
    Bosch-Campos, Ana
    Schwartz, Sarit
    Rodrik-Outmezguine, Vanessa
    Berger, Michael
    Jose, Baselga
    Rosen, Neal
    CANCER RESEARCH, 2015, 75
  • [40] REDUCED CANCER CELL SENSITIVITY TO TUMOR TREATING FIELDS (TTFIELDS) THROUGH ACTIVATION OF THE PI3K/AKT/MTOR SIGNALING PATHWAY CAN BE MITIGATED USING PI3K INHIBITORS OR PI3K/MTOR DUAL INHIBITORS
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2021, 23 : 84 - 84
12345